Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

PODD

Insulet Corporation

Dec 13 • 04:00PM ET

269.34

Dollar change -2.39
Percentage change -0.88	%

Healthcare • Medical Devices • USA • NASD

Peers: DXCM JNJ ABT MDT EW SYK TNDM BSX BAX LIVN

| Held by: VTI VOO SPY IVV VB VO RSP XLV VUG VBK

Scroll to Statements

Index	S&P 500	P/E	45.80	EPS (ttm)	5.88	Insider Own	0.56%	Shs Outstand	70.14M	Perf Week	1.46%
Market Cap	18.73B	Forward P/E	68.83	EPS next Y	3.91	Insider Trans	-5.24%	Shs Float	69.75M	Perf Month	0.10%
Income	420.90M	PEG	1.99	EPS next Q	1.03	Inst Own	102.01%	Short Float	4.37%	Perf Quarter	15.16%
Sales	1.98B	P/S	9.44	EPS this Y	9.31%	Inst Trans	-1.55%	Short Ratio	5.46	Perf Half Y	34.37%
Book/sh	15.94	P/B	16.90	EPS next Y	21.77%	ROA	15.32%	Short Interest	3.05M	Perf Year	31.49%
Cash/sh	12.98	P/C	20.75	EPS next 5Y	23.00%	ROE	48.79%	52W Range	160.19 - 279.77	Perf YTD	24.13%
Dividend Est.	-	P/FCF	82.53	EPS past 5Y	122.47%	ROI	17.01%	52W High	-3.73%	Beta	1.22
Dividend TTM	-	Quick Ratio	2.76	Sales past 5Y	24.75%	Gross Margin	70.01%	52W Low	68.14%	ATR (14)	7.06
Dividend Ex-Date	-	Current Ratio	3.64	EPS Y/Y TTM	249.22%	Oper. Margin	15.42%	RSI (14)	59.53	Volatility	3.07% 2.41%
Employees	3000	Debt/Eq	1.25	Sales Y/Y TTM	27.42%	Profit Margin	21.22%	Recom	1.64	Target Price	287.90
Option/Short	Yes / Yes	LT Debt/Eq	1.21	EPS Q/Q	53.09%	Payout	0.00%	Rel Volume	0.98	Prev Close	271.73
Sales Surprise	4.69%	EPS Surprise	38.87%	Sales Q/Q	25.70%	Earnings	Nov 07 AMC	Avg Volume	558.63K	Price	269.34
SMA20	0.99%	SMA50	7.47%	SMA200	30.98%	Trades		Volume	549,055	Change	-0.88%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-06-24	Initiated	Bernstein	Outperform	$300
May-30-24	Initiated	Redburn Atlantic	Buy	$235
May-07-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$200
Dec-21-23	Upgrade	Robert W. Baird	Neutral → Outperform	$180 → $238
Dec-04-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$185 → $234
Oct-02-23	Upgrade	Jefferies	Hold → Buy	$260 → $240
Aug-21-23	Upgrade	Citigroup	Neutral → Buy	$273 → $265
Aug-21-23	Downgrade	Robert W. Baird	Outperform → Neutral	$320 → $219
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$343
Jan-26-23	Initiated	Wolfe Research	Peer Perform
Nov-04-22	Upgrade	Piper Sandler	Neutral → Overweight	$235 → $340
Oct-18-22	Initiated	Barclays	Equal Weight	$238
Oct-12-22	Initiated	Jefferies	Hold	$260
Jul-11-22	Downgrade	Citigroup	Buy → Neutral	$310 → $250
Mar-02-22	Resumed	BofA Securities	Buy	$300
Feb-03-22	Upgrade	BTIG Research	Neutral → Buy	$320
Feb-02-22	Upgrade	UBS	Neutral → Buy	$325
Jan-31-22	Upgrade	Oppenheimer	Perform → Outperform	$300 → $275
Jul-21-21	Resumed	Cowen	Outperform	$285 → $310
May-25-21	Initiated	Barclays	Overweight	$300

Show Previous Ratings

Dec-13-24 09:50AM	Why Insulet (PODD) is a Top Momentum Stock for the Long-Term (Zacks)
Dec-11-24 02:59PM	Inari Medical Stock Gets RS Rating Upgrade (Investor's Business Daily)
Dec-05-24 07:19AM	Insulet awarded $452M in EOFlow patent fight (MedTech Dive)
Dec-04-24 04:28PM	Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court (Business Wire)
Dec-03-24 02:51PM	Novocure Stock Earns 96 RS Rating (Investor's Business Daily)
09:45AM	Loading…
Nov-29-24 09:45AM	Here's Why Insulet (PODD) is a Strong Growth Stock (Zacks)
Nov-21-24 08:27AM	Insulet adds Abbotts FreeStyle Libre 2 Plus to Omnipod 5s compatibility roster (Medical Device Network)
Nov-20-24 08:30AM	Insulet Announces Omnipod 5 System is Now Compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the U.S. (Business Wire)
Nov-15-24 06:00AM	Insulet to Present at Upcoming Investor Conferences (Business Wire)
Nov-12-24 09:45AM	Why Insulet (PODD) is a Top Growth Stock for the Long-Term (Zacks)
06:45AM	Insulet price target raised to $317 from $234 at Morgan Stanley (TipRanks)
Nov-11-24 05:21PM	Insulet CEO on earnings, GLP-1 and election impact (CNBC TV)
Nov-08-24 04:39PM	S&P 500 Gains and Losses Today: Axon Shares Surge as Taser Maker Tops Estimates (Investopedia) +9.40%
04:11PM	Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues (Investor's Business Daily)
01:40PM	Top Stock Movers Now: Axon Enterprise, Sweetgreen, Akamai Technologies, and More (Investopedia)
12:55PM	Loading…
12:55PM	Costco Stock Breaks Out Past Buy Point, Reaches All-Time High (Investor's Business Daily)
06:01AM	Tandem, Insulet tout Type 2 expectations as tech attracts new users (MedTech Dive)
02:27AM	Insulet Corp (PODD) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansions (GuruFocus.com)
Nov-07-24 05:30PM	Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:15PM	Insulet (PODD) Q3 Earnings and Revenues Top Estimates (Zacks)
04:10PM	Insulet: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency1) (Business Wire)
Nov-04-24 09:16AM	Stay Ahead of the Game With Insulet (PODD) Q3 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Nov-01-24 06:00AM	Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November (Business Wire)
Oct-31-24 10:02AM	Insulet (PODD) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-30-24 01:06PM	Insulet rolls out iPhone app for Omnipod 5 insulin pump in US (Medical Device Network)
Oct-29-24 04:01PM	Omnipod 5 App for iPhone Now Fully Available in the United States (Business Wire)
Oct-28-24 02:08PM	Here Is Why Analysts See More Growth After Meta's Impressive Gains (Investor's Business Daily)
Oct-15-24 04:01PM	Solventum Stock Earns 81 RS Rating (Investor's Business Daily)
07:37AM	Insulet price target raised to $260 from $250 at BTIG (TipRanks)
12:32PM	Loading…
Oct-11-24 12:32PM	Is Insulet Corporation (NASDAQ:PODD) The Top Stock With Improving Technical Ratings According To Piper Sandler? (Insider Monkey)
Oct-10-24 09:00AM	National Campaign Launches to Combat Diabetes Stigma Using Comedy (PR Newswire)
Oct-09-24 05:53PM	Insulet Corp (PODD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance (GuruFocus.com)
08:55AM	Heres Why ClearBridge Growth Strategy Increased its Position in Insulet Corporation (PODD) (Insider Monkey)
Oct-07-24 03:04PM	FMR LLC Bolsters Position in Insulet Corp with Strategic Share Acquisition (GuruFocus.com)
Oct-01-24 08:07AM	Fidelity Growth Strategies Fund Trimmed Insulet Corporation (PODD) to Manage the Position Size (Insider Monkey)
Sep-30-24 06:00AM	Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024 (Business Wire)
Sep-12-24 01:01PM	Insider Sale: Director Timothy Scannell Sells 5,000 Shares of Insulet Corp (PODD) (GuruFocus.com)
Sep-07-24 01:16AM	Insulets (PODD) Sales And Margins Surpassed Expectations (Insider Monkey)
Sep-05-24 07:22PM	Analyst Report: Insulet Corporation (Morningstar Research)
Sep-04-24 05:00PM	S&P 500 Gains and Losses Today: Dollar Tree Stock Tumbles After Earnings Miss (Investopedia)
Aug-30-24 10:35AM	Analyst Report: Insulet Corporation (Morningstar Research)
07:20AM	Why Insulet Stock Was Zooming Higher This Week (Motley Fool)
01:46AM	Insider Sale at Insulet Corp (PODD): SVP & Chief Technology Officer Mark Field Sells Shares (GuruFocus.com)
Aug-28-24 05:25PM	S&P 500 Gains and Losses Today: Supermicro Stock Plunges on Annual Report Delay (Investopedia) +6.15%
Aug-27-24 05:36PM	S&P 500 Gains and Losses Today: Medical Device Makers ResMed, Insulet Lead Index (Investopedia) +6.58%
12:48PM	Top Stock Movers Now: Nvidia, Insulet, Paramount Global, and More (Investopedia)
11:32AM	This Healthcare Stock Is the Best Performer in the S&P 500 After FDA Approval (Barrons.com)
10:08AM	Insulets Trang Ly on overcoming clinical inertia in diabetes care (MedTech Dive)
08:23AM	Insulet Omnipod cleared by FDA for type 2 diabetes (Medical Device Network)
Aug-26-24 04:20PM	Omnipod 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes (Business Wire)
01:37PM	Insulet expands Omnipod 5 pump to people with Type 2 diabetes (MedTech Dive)
Aug-20-24 05:25PM	S&P 500 Gains and Losses Today: Palo Alto Networks Surges After Earnings Beat (Investopedia) -6.87%
05:21PM	These Two Stocks Plunged After Eli Lilly Drug Study Showed Diabetes Promise (Investopedia)
12:11PM	Top Stock Movers Now: Boeing, Lowe's, Netflix, Eli Lilly, and More (Investopedia)
06:00AM	Insulet to Present at Upcoming Investor Conferences (Business Wire)
Aug-16-24 08:57PM	Insulet Corporation (PODD): This Diabetes Stock Is A Good Addition To Your Portfolio Now (Insider Monkey)
Aug-14-24 03:00AM	Insulet Celebrates Grand Opening of 400,000-square-foot Manufacturing Facility in Malaysia (Business Wire)
Aug-10-24 01:04AM	Decoding Insulet Corp (PODD): A Strategic SWOT Insight (GuruFocus.com)
Aug-09-24 05:34PM	Analyst Report: Insulet Corporation (Morningstar Research) -8.81%
05:31PM	S&P 500 Gains and Losses Today: Expedia Soars as International Demand Drives Earnings Beat (Investopedia)
05:15PM	Insulin Pump Maker Insulet's Stock Slumps on User Growth Concerns (Investopedia)
01:19PM	Insulet Is the Worst Stock in S&P 500 Today, Despite Solid Earnings. Heres Why. (Barrons.com)
12:49PM	Top Stock Movers Now: Sweetgreen, Intel, Akamai Technologies, and More (Investopedia)
10:48AM	Insulin Pump Maker Insulet's Growth Catalysts Set to Boost Revenue in 2025: Analyst (Benzinga)
09:24AM	Insulet (PODD) Q2 Earnings Miss Estimates, '24 Sales View Raised (Zacks)
Aug-08-24 08:07PM	Insulet inventory pressures cloud annual revenue forecast raise (Reuters)
05:30PM	Insulet (PODD) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:15PM	Insulet (PODD) Q2 Earnings Miss Estimates (Zacks)
04:07PM	Insulet: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Insulet Reports Second Quarter 2024 Revenue Increase of 23% Year-Over-Year (Business Wire)
Aug-07-24 09:02AM	Earnings To Watch: Insulet Corp (PODD) Reports Q2 2024 Result (GuruFocus.com)
Aug-05-24 09:16AM	Unlocking Q2 Potential of Insulet (PODD): Exploring Wall Street Estimates for Key Metrics (Zacks)
Aug-01-24 10:01AM	Insulet (PODD) Earnings Expected to Grow: Should You Buy? (Zacks)
Jul-26-24 09:37AM	Are Ozempic Jitters to Blame for DexCom's Stock-Price Plunge? (The Wall Street Journal)
06:00AM	Insulet Reports Preliminary Second Quarter 2024 Revenue Results (Business Wire)
Jul-18-24 12:00PM	All You Need to Know About Insulet (PODD) Rating Upgrade to Strong Buy (Zacks)
Jul-16-24 08:45AM	CereVasc Announces Appointments of New Directors (PR Newswire)
Jul-08-24 06:00AM	Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024 (Business Wire)
Jun-25-24 02:32PM	Insulet Points Its Insulin Pump at the Big Diabetes Market: Type 2 (Barrons.com)
Jun-24-24 04:08PM	Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks (Bloomberg)
08:36AM	Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes (Zacks)
08:13AM	Insulet seeks label expansion of Omnipod 5 for Type 2 diabetes (MedTech Dive)
07:13AM	Insulet plans label expansion for Omnipod in type 2 diabetes (Medical Device Network)
Jun-21-24 06:30PM	Insulets SECURE-T2D Pivotal Trial Results Demonstrate Omnipod 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes (Business Wire)
10:59AM	Insulet (PODD) Faces Increasing Competition (Insider Monkey)
08:33AM	Insulet (PODD) Unveils Key Achievements for the Omnipod 5 System (Zacks)
Jun-20-24 06:05AM	Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands (Business Wire)
06:00AM	Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates (Business Wire)
Jun-19-24 06:02AM	The 3 Best Diabetes Stocks to Buy in June 2024 (InvestorPlace)
Jun-17-24 07:01PM	Insider Sale at Insulet Corp (PODD) by SVP & Chief Technology Officer Mark Field (GuruFocus.com)
Jun-13-24 09:24AM	Is Insulet (PODD) Stock an Apt Pick for Your Portfolio Now? (Zacks)
Jun-11-24 07:00PM	Insider Sale: Director Timothy Scannell Sells 7,000 Shares of Insulet Corp (PODD) (GuruFocus.com)
Jun-06-24 06:19AM	7 Stocks That Could Safely 10X by 2030 (InvestorPlace)
May-30-24 09:59AM	PayPal upgraded, UiPath downgraded: Wall Street's top analyst calls (The Fly)
May-28-24 06:00AM	Insulet to Present at the Jefferies Global Healthcare Conference (Business Wire)
May-23-24 09:50AM	Here's Why Insulet (PODD) is a Strong Momentum Stock (Zacks) -5.68%
May-22-24 09:45AM	Why Insulet (PODD) is a Top Growth Stock for the Long-Term (Zacks)
May-19-24 02:08PM	Follow the Whales: 3 Genius Stocks the Smart Money Is Piling Into for Triple-Digit Gains (InvestorPlace)
May-16-24 07:42AM	Dexcom details plans for over-the-counter CGM as insulin pump firms seek Type 2 coverage (MedTech Dive)

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Budden Lauren	Group VP, CAO and Controller	Dec 10 '24	Sale	275.62	915	252,192	5,733	Dec 11 04:00 PM
Budden Lauren	Officer	Dec 10 '24	Proposed Sale	275.62	915	252,194		Dec 10 05:18 PM
BORIO LUCIANA	Director	Nov 12 '24	Sale	274.80	508	139,598	2,790	Nov 13 04:01 PM
BORIO LUCIANA	Director	Nov 12 '24	Proposed Sale	274.81	508	139,602		Nov 12 04:01 PM
Hopfield Jessica	Director	Sep 11 '24	Option Exercise	29.87	7,628	227,848	34,545	Sep 12 04:07 PM
Hopfield Jessica	Director	Sep 11 '24	Sale	225.26	7,628	1,718,283	26,917	Sep 12 04:07 PM
Scannell Timothy J	Director	Sep 10 '24	Sale	225.84	5,000	1,129,200	30,586	Sep 11 04:13 PM
Hopfield Jessica	Director	Sep 11 '24	Proposed Sale	225.26	7,628	1,718,283		Sep 11 03:40 PM
Field Mark N	SVP & Chief Technology Officer	Sep 09 '24	Sale	220.87	1,383	305,463	9,761	Sep 10 04:16 PM
Budden Lauren	Group VP, CAO and Controller	Sep 09 '24	Sale	221.41	1,506	333,443	6,609	Sep 10 04:15 PM
Scannell Timothy J	Director	Sep 10 '24	Proposed Sale	225.84	5,000	1,129,210		Sep 10 02:27 PM
Field Mark N	Officer	Sep 09 '24	Proposed Sale	220.87	1,383	305,465		Sep 09 04:50 PM
Budden Lauren	Officer	Sep 09 '24	Proposed Sale	221.41	1,506	333,436		Sep 09 01:20 PM
Singh Prem	SVP, Global Operations	Aug 30 '24	Sale	202.27	1,824	368,940	3,656	Sep 03 04:30 PM
Singh Prem	Officer	Aug 30 '24	Proposed Sale	202.27	1,824	368,938		Aug 30 03:22 PM
Chadwick Ana Maria	EVP, CFO & Treasurer	Aug 29 '24	Buy	206.00	100	20,600	13,314	Aug 29 04:17 PM
Field Mark N	SVP & Chief Technology Officer	Aug 28 '24	Sale	203.00	1,387	281,561	11,347	Aug 29 04:14 PM
Field Mark N	Officer	Aug 28 '24	Proposed Sale	203.00	1,387	281,561		Aug 28 04:02 PM
Field Mark N	SVP & Chief Technology Officer	Jun 14 '24	Sale	199.96	1,500	299,940	12,875	Jun 17 04:11 PM
Scannell Timothy J	Director	Jun 10 '24	Sale	190.51	7,000	1,333,570	35,586	Jun 11 04:12 PM
Field Mark N	SVP & Chief Technology Officer	Jun 10 '24	Sale	190.43	2,131	405,806	14,375	Jun 11 04:11 PM
BORIO LUCIANA	Director	Jun 04 '24	Sale	182.58	360	65,729	3,298	Jun 05 04:13 PM
Scannell Timothy J	Director	May 28 '24	Option Exercise	32.33	18,267	590,595	45,886	May 29 04:04 PM
Scannell Timothy J	Director	May 28 '24	Sale	180.90	3,300	596,970	42,586	May 29 04:04 PM
Petrovic Shacey	Director	Feb 28 '24	Option Exercise	92.11	11,609	1,069,305	14,176	Feb 29 04:37 PM
Petrovic Shacey	Director	Feb 28 '24	Sale	162.92	11,609	1,891,338	2,567	Feb 29 04:37 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PODD

Insulet Corporation

Upgrade your FINVIZ experience